title: Off-label indications for mifepristone in gynecology and obstetrics.
authors.affiliation: Gynuity Health Projects, 15 E. 26th Street, Suite 801, New York, NY 10010. Electronic address: idzuba@gynuity.org.
authors.forename: Ilana G
authors.initials: IG
authors.lastname: Dzuba
authors.affiliation: Ibis Reproductive Health, 1330 Broadway, Suite 1100, Oakland, CA 94612; Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, San Francisco, CA 94110. Electronic address: dgrossman@ibisreproductivehealth.org.
authors.forename: Daniel
authors.initials: D
authors.lastname: Grossman
authors.affiliation: Department of Obstetrics and Gynecology, Perelman School of Medicine, University of Pennsylvania, 3400 Spruce Street, 1000 Courtyard, Philadelphia, PA 19104. Electronic address: courtney.schreiber@uphs.upenn.edu.
authors.forename: Courtney A
authors.initials: CA
authors.lastname: Schreiber
mesh_terms: D000019:Abortifacient Agents / Q000627:therapeutic use*; D000028:Abortion, Induced / Q000331:legislation & jurisprudence*; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D005260:Female; D006176:Gynecology; D006801:Humans; D015735:Mifepristone / Q000627:therapeutic use*; D016595:Misoprostol / Q000627:therapeutic use*; D009774:Obstetrics; D056687:Off-Label Use / Q000331:legislation & jurisprudence*; D011247:Pregnancy
chemical_list: D000019:Abortifacient Agents; D016595:Misoprostol; D015735:Mifepristone